These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin converting enzyme inhibitors. Breckenridge A Br Med J (Clin Res Ed); 1988 Feb; 296(6622):618-20. PubMed ID: 2832034 [No Abstract] [Full Text] [Related]
24. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A; Boner G; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825 [TBL] [Abstract][Full Text] [Related]
28. [Angioneurotic edema of the tongue, induced by administration of ACE inhibitors]. Zech J; Tasman A; Maier H HNO; 1990 Apr; 38(4):143-4. PubMed ID: 2193006 [TBL] [Abstract][Full Text] [Related]
29. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. Borghi C; Cosentino E; De Sanctis D Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921 [TBL] [Abstract][Full Text] [Related]
30. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"]. Düsing R; Müller U MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605 [No Abstract] [Full Text] [Related]
32. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. Golik A; Zaidenstein R; Dishi V; Blatt A; Cohen N; Cotter G; Berman S; Weissgarten J J Am Coll Nutr; 1998 Feb; 17(1):75-8. PubMed ID: 9477394 [TBL] [Abstract][Full Text] [Related]
33. Hazards of fad diets in patients treated with ACE inhibitors. Sisodiya S; Hoffbrand BI Br J Hosp Med; 1993 Oct 20-Nov 2; 50(8):486-7. PubMed ID: 8275290 [No Abstract] [Full Text] [Related]
34. ACE-inhibitors in the treatment of elderly hypertensives. M'Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; Van Hoof R; Amery A Geriatrics; 1987 Jun; 42(6):45-9. PubMed ID: 3034739 [TBL] [Abstract][Full Text] [Related]
35. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension. Weber MA J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978 [No Abstract] [Full Text] [Related]
37. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors]. Alimento M; Campodonico J; Santambrogio G; Rossi M; Trabattoni D; Celeste F; Guazzi M Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376 [TBL] [Abstract][Full Text] [Related]
38. [Angiotensin-converting enzyme inhibition: side effects and risks]. Schilling H; Scheler F Z Kardiol; 1988; 77 Suppl 3():47-54. PubMed ID: 2850687 [TBL] [Abstract][Full Text] [Related]
39. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention. Cooke HM; De Besse A Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361 [TBL] [Abstract][Full Text] [Related]